The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Sept 14 Board Meeting Agenda item 13d Other policy issues including consultations
Since last meeting
The Board meeting provides a chance to review the latest developments in terms of the Juncker Commission, the personalities nominated to take portfolios of relevance to EAHP (e.g. DG SANCO, DG Enterprise), as well as internal reshuffling of portfolios (e.g. proposed move of pharmaceutical responsibilities back to DG Enterprise), what this means for the areas of interest to EAHP, and potential responses to these.
Proposed new Commission team here.
Proposed new means of functioning Commission legislative initiative here.
Parliament hearing timetable here.
The PAO will also give an update on current consultations and an overview of miscellaneous European policy developments of potential interest or need of response.